April 16, 2026 BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100
April 16, 2026 Inshurents Launches to Protect the Fastest-Growing Force in the Economy: Women-Owned Businesses